BBA Clin. 2015 Mar 12;3:257-75. doi: 10.1016/j.bbacli.2015.03.003. eCollection 2015.
The fate of chemoresistance in triple negative breast cancer (TNBC).
O'Reilly EA1, Gubbins L2, Sharma S1, Tully R2, Guang MH2, Weiner-Gorzel K2, McCaffrey J3, Harrison M4, Furlong F5, Kell M6, McCann A2.
Author information
- 1UCD Conway Institute of Biomolecular and Biomedical Research, UCD School of Medicine and Medical Science (SMMS), Belfield, Dublin 4, Ireland ; Department of Surgery, Mater Misericordiae Hospital, Dublin 7, Ireland.
- 2UCD Conway Institute of Biomolecular and Biomedical Research, UCD School of Medicine and Medical Science (SMMS), Belfield, Dublin 4, Ireland.
- 3Department of Oncology, Mater Misericordiae Hospital, Dublin 7, Ireland.
- 4Department of Pathology, Mater Misericordiae Hospital, Dublin 7, Ireland.
- 5School of Pharmacy, Queens University Belfast, Belfast BT7 1NN, UK.
- 6Department of Surgery, Mater Misericordiae Hospital, Dublin 7, Ireland.